Ophiomics

This afternoon our CSO Joana Cardoso Vaz takes the stage at XIII Jornadas do Centro Hepato-Bilio-Pancreático e de Transplantação 🎤 Join us today for her insightful talk on "Biomarkers and Machine Learning: New Selection Criteria for Transplant and Resection in Hepatocellular Carcinoma". 📍 After the talk, stop by our booth to keep the conversation going, meet our team, and explore our latest advancements. Let’s continue pushing forward with innovative, impactful solutions together💡 #Ophiomics #HepatoPredict #LiverCancer #HCC #LiverPrecisionMedicine #CHBPT #Biomarkers #Machinelearning #AI

📢 We will be attending the XIII Jornadas do Centro Hepato-Bilio-Pancreático e de Transplantação showcasing HepatoPredict, our innovative prognostic tool designed to support clinical decisions for liver transplantation in patients with Hepatocellular Carcinoma 🩺✨ Come visit us to learn how HepatoPredict can help advance care for patients with Hepatocellular Carcinoma. Let’s work together toward a brighter future for liver health! 💪 #Ophiomics #HepatoPredict #LiverCancer #HCC #LiverPrecisionMedicine #CHBPT

📣 October is Liver Cancer Awareness Month🎗 ! 👉 Follow us and visit our website to discover innovative diagnostic solutions and learn how we’re committed to improving liver health . #livercancer #LiverCancerAwarenessMonth #HCC #Ophiomics #HepatoPredict #precisionlivermedicine References: (1) International Agency for Research on Cancer. Liver Cancer fact sheet (2022) (2) Rumgay H et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77:1598–606.  

Sayonara Biojapan 2024, see you next year! It was great to meeet old and new friends, and to discuss avenues for collaboration with Japanese (and beyond) partners. Thank you EU-Japan Centre for Industrial Cooperation for the opportunity and all the support. Kampai!

We're #hiring a new Financial And Administrative Manager in Lisbon. Apply today or share this post with your network.

https://lnkd.in/dnE334ZB

Ophiomics is present at #EASLCongress 2024 in Milan. Visit us at Booth bt3 to learn everything about our prognostic tool on liver cancer #HepatoPredict. Is is being a fantastic meeting!😃

I am very proud to announce that our poster entitled “Prognosticating hepatocellular carcinoma before and after liver transplantation with HepatoPredict”, that was accepted for #EASLCongress, was selected for oral presentation today at the Track Hub: General Hepatology! It was fantastic to talk about our tool #HepatoPredict to such an audience!😃

Ophiomics is present at #EASLCongress 2024 in Milan. Visit us at Booth bt3 to learn everything about our prognostic tool on liver cancer #HepatoPredict. Is is being a fantastic meeting!😃

Lets connect in Munich https://www.health.tech/